Health Care & Life Sciences » Biotechnology | ISU abxis Co. Ltd.

ISU abxis Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
8,164
7,097
11,471
19,055
19,459
Cost of Goods Sold (COGS) incl. D&A
4,036
3,794
5,909
8,055
9,970
Gross Income
4,128
3,303
5,562
11,000
9,489
SG&A Expense
10,404
9,616
10,612
11,754
14,265
EBIT
6,319
6,340
5,092
792
4,817
Unusual Expense
-
2,424
2,589
-
-
Non Operating Income/Expense
5
90
212
231
118
Interest Expense
2,272
2,975
2,232
1,425
707
Pretax Income
8,191
11,198
9,773
2,038
5,481
Consolidated Net Income
8,191
11,198
9,773
2,038
5,481
Net Income
8,191
11,198
9,773
2,038
5,481
Net Income After Extraordinaries
8,191
11,198
9,773
2,038
5,481
Net Income Available to Common
8,191
11,198
9,773
2,038
5,481
EPS (Basic)
612.15
747.68
563.78
99.04
271.00
Basic Shares Outstanding
13
15
17
21
20
EPS (Diluted)
612.85
747.72
563.53
98.69
271.35
Diluted Shares Outstanding
13
15
17
21
20
EBITDA
4,266
4,254
3,034
1,723
2,196
Other Operating Expense
44
27
42
38
41
Non-Operating Interest Income
405
451
351
410
162

About ISU abxis Co.

View Profile
Address
5th Floor, Global R&D Centre C-Dong
Seongnam-si GY 13488
Korea, Republic Of
Employees -
Website http://www.abxis.com
Updated 09/14/2018
ISU Abxis Co., Ltd. is engaged in pharmaceutical business. It operates through the following business divisions: Bio-Pharmaceutical and Other. The company was founded on March 28, 2001 and is headquartered in Seongnam-si, South Korea.